Finally some NZ media articles are calling for accountability for some of the mistakes of the Covid years including the failure to warn the public of the risk of myocarditis from mRNA vaccines. In the USA, Fauci’s diaries reveal he knew about the lab origin of Covid and sought to mislead the public. Senator Rand Paul has referred Fauci to the justice department after his refusal to answer questions from a Senate committee. These small steps come after six years of persistent questioning on the part of thousands of people around the world. However, those injured still have little or in most cases no compensation or acknowledgement. More to the point, while many have been doggedly calling for accountability for Covid, some of those responsible are not just unrepentant but have, throughout the intervening six years, developed and promoted a biotech agenda fraught with novel risks to public health.
For example, GLP-1 weight loss drugs have been hailed as a miracle medical breakthrough which will turbo charge preventive approaches to type 1 diabetes, heart disease, stroke, osteoarthritis, fatty liver disease, some cancers including breast, colorectal, uterine, kidney, and pancreatic cancers, as well as anxiety and depression linked to obesity. This is actually hope not reality.
Figures published by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) show that they have received more than 150,000 reports of adverse reactions to the GLP-1 weight-loss drugs available through the NHS. These include liraglutide, also known as Saxenda; semaglutide, offered as Wegovy and Ozempic; and tirzepatide, also known as Mounjaro. MHRA operates a yellow card adverse reaction system which, like our NZ CARM, is known to be heavily under-reported, in some cases by a factor of ten. MHRA reported that 16,000 of the adverse reactions were rated as serious, resulting in 150 deaths to date.
There are an estimated 1.6 million people in the UK taking weight loss drugs. The MHRA figures show that at least 10% of these people suffered adverse reactions to GLP-1 drugs, almost certainly many times more. For at least 1% (1 in a hundred) these reactions are serious enough to require medical interventions. 1 in 10,000 are likely to die. These rates are staggeringly high. Before the Covid pandemic, any drug associated with these rates of adverse reactions and death would have been withdrawn from use and sale.
Instead Dr Alison Cave, the MHRA’s chief safety officer, in an act of doublespeak that defies common sense, assessed the mammoth risk rates as ‘very small’, saying:
“Patient safety is the MHRA’s top priority and we continually monitor the safety and efficacy of all licensed medicines. For the vast majority of patients who are prescribed GLP-1s, they are safe and effective medicines, which deliver significant health benefits. The risk of developing these severe side-effects is very small, but it is important that patients and healthcare professionals are aware and alert to the associated symptoms.”
Such smooth talking reassurances perfectly mimic the pronouncements of the drug manufacturers. A Novo Nordisk spokesperson said of its GLP-1 drugs: “At Novo Nordisk we care deeply about patient safety. Like all medicines, treatments used for chronic conditions can have side-effects, and these can vary from person to person. That is why medicines should be prescribed by, and used under the supervision of, a healthcare professional, who can consider the potential benefits and risks for each individual.”
The most common adverse symptoms of GLP-1 weight loss drugs include gastrointestinal conditions like nausea, vomiting, stomach pain, diarrhea and constipation. In more serious cases these reactions can lead to bowel obstruction, perforation or leaking through the bowel wall. Other adverse effects include bone and muscle mass loss and nutrient deficiencies. Long term changes to mental health have also been reported including anhedonia and emotional blunting—loss of pleasure or interest in regular activities, sleep disturbance, depression and anxiety associated with loss of food related emotional coping mechanisms. The most serious reactions include gallbladder problems, blindness, elevated heart rate, and necrotising pancreatitis. MHRA had logged 1,143 cases of severe pancreatitis by the start of this year resulting in 17 deaths, prompting MHRA to attach a warning to GLP-1 products.
GLP-1 drugs function by modifying the cellular signalling and downstream gene expression of the GLP1R and GIPR genes contained in a person’s DNA, thereby altering physiological processes which control appetite. The huge range of adverse effects illustrate how an intervention designed to affect a single pathway of genetic expression can and does lead to a range of unexpected outcomes. This is because our genetic system of physiological control is multidimensional and multitasking, The simplistic notion promoted to the public that one gene causes one effect is completely wrong—a dangerous over simplification of the complexity of genetic systems
GLP-1 drugs present just one example of the changing face of medication and patient safety since the Covid era began. This represents a step away from proven solutions which really do work with high success rates free from side effects like improved diet, exercise, sunshine, fresh air, lifestyle and meditation. Just as changing the fundamental frequency of a digital watch would alter all of its functions and distort displayed readings, novel biotech drugs force our physiology to operate within biomolecular parameters far removed from previously understood physiological norms. This results in a wide range of adverse health conditions that require constant monitoring which can only be carried out by highly qualified trained health professionals. These are not safe drugs, they are ongoing experiments affecting whole populations whose outcomes should be recognisably dangerous. We are being herded into programs whereby we lose control of our body and fall into the hands of drug companies with deceptive messaging whose major focus is profit, not people.
Novo Nordisk commands resources which dwarf those of the NZ health service. It’s second-quarter 2026 adjusted operating profit reached 33.4 billion Danish kroner (approx. NZ$9.4 billion—five times the total NZ drug budget), an 11% increase driven heavily by high demand for its GLP-1 medications like Ozempic and the Wegovy weight-loss injection and new pill. GLP-1 products generate the vast majority of the company’s total revenue and profit streams. According to USA Today, some 4,400 US patients have filed lawsuits against weight-loss drug manufacturers since 2023. Test trials are not expected until 2027.
You may be horrified by the GLP-1 statistics we have presented here, but this is just the tip of the iceberg. Dozens of novel drugs that directly affect genetic expression are being approved by medical regulators without sufficient consideration of their short and long term effects. More is to come. A BBC article this week headlines “Artificial Intelligence used to design brand new viruses. The article reports the creation of 16 entirely synthetic viral bacteriophages, which were not constructed from live material found in nature. The viruses were successfully used to kill E. Coli bacteria. The plan is to develop medicines to replace antibiotics whose effectiveness is waning as drug resistant strains of bacteria develop due to overuse and insertion in the food chain.
What could possibly go wrong? You don’t have to go far to find out, In a commentary accompanying the publication announcing the virus creation breakthrough in the journal Science, Dr Thomas Inglesby and Dr Moritz Hanke from the prestigious Center for Health Security at Johns Hopkins University wrote that the findings raise “urgent biosafety and biosecurity questions”. They said it was no longer a question of “whether generative viral genome design will exist” but whether it can be used without “enabling serious harm”. The public will be on the sharp end of this harm.
As many honest and dedicated campaigners are still stuck struggling to work through the fallout from the Covid virus and Covid vaccines along with the pharmaceutical PR barrage that has obscured the truth, the biotech industry is forging ahead with programs that are irrevocably altering medicine, agriculture and the processed food industry. These programs are creating novel serious risks to individual health with horrific long term consequences for public health. It is a system that became supercharged by the allure of the vast Covid era profits, built on rogue research that ignored risk and promised miracle cures unjustified by hard evidence. If it is not reigned in soon, the Covid era will soon be replayed on an even bigger stage. All the same fear tactics will be employed to manipulate acceptance of medical mandates while critics and whistleblowers are silenced. There is no time to lose.




